Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms
- PMID: 21489080
- DOI: 10.1111/j.1742-1241.2011.02638.x
Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms
Abstract
Aims: To investigate the diagnostic value of the International Prostate Symptom Score (IPSS) voiding-to-storage subscore ratio (IPSS-V/S) in male lower urinary tract symptoms (LUTS).
Methods: A total of 253 men with LUTS were enrolled from January 2005 to July 2010. The voiding (IPSS-V) and storage IPSS (IPSS-S) subscores were recorded separately by the patients themselves. The IPSS-V/S was calculated and compared among various aetiologies based on videourodynamic studies. Receiver operating characteristics (ROC) curves were constructed for comparing the diagnostic value of various non-invasive methods for predicting failure to voiding and storage lower urinary tract dysfunction (LUTD).
Results: Patients with failure to voiding LUTD, including benign prostatic obstruction (n = 72), bladder neck dysfunction (n = 19), urethral stricture (n = 3) and poor relaxation of the urethral sphincter (n = 32), had mean IPSS-V/S scores > 1. In contrast, patients who were urodynamically normal (n = 2) or had failure to storage LUTD, including idiopathic detrusor overactivity (n = 84), increased bladder sensation (n = 37), and detrusor overactivity and impaired contractility (n = 4), had IPSS-V/S scores ≤ 1. When IPSS-V/S was used to differentiate male LUTS, failure to voiding LUTD was found in 81.2% of patients with IPSS scores > 1, while failure to storage LUTD was found in 75.7% of patients with IPSS-V/S ≤ 1. The area under ROC curve of IPSS-V/S was higher than for other non-invasive methods for predicting failure to voiding and storage LUTD.
Conclusion: Measuring IPSS subscores and calculating IPSS-V/S is a simple and useful method to differentiate failure to voiding and failure to storage LUTD in men with LUTS. IPSS-V/S may provide a guide for the initial treatment, especially for primary care physicians without access to urological studies.
© 2011 Blackwell Publishing Ltd.
Comment in
-
Editorial comment regarding diagnostic value of International Prostate Symptom Score (IPSS) voiding-to-storage subscore ratio in male lower urinary tract symptoms.Int J Clin Pract. 2011 May;65(5):519. doi: 10.1111/j.1742-1241.2011.02675.x. Int J Clin Pract. 2011. PMID: 21489073 No abstract available.
Similar articles
-
International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.Int Urogynecol J. 2013 Feb;24(2):263-7. doi: 10.1007/s00192-012-1818-8. Epub 2012 May 16. Int Urogynecol J. 2013. PMID: 22588143
-
Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.Int J Clin Pract. 2014 Jun;68(6):743-8. doi: 10.1111/ijcp.12364. Epub 2014 Jan 29. Int J Clin Pract. 2014. PMID: 24471413
-
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26. BJU Int. 2008. PMID: 18510659 Clinical Trial.
-
Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction.Tzu Chi Med J. 2019 Nov 18;32(2):121-130. doi: 10.4103/tcmj.tcmj_178_19. eCollection 2020 Apr-Jun. Tzu Chi Med J. 2019. PMID: 32269943 Free PMC article. Review.
-
Defining female voiding dysfunction: ICI-RS 2011.Neurourol Urodyn. 2012 Mar;31(3):313-6. doi: 10.1002/nau.22213. Epub 2012 Mar 13. Neurourol Urodyn. 2012. PMID: 22415792 Review.
Cited by
-
Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia.Transl Androl Urol. 2024 Jun 30;13(6):930-939. doi: 10.21037/tau-23-655. Epub 2024 Jun 13. Transl Androl Urol. 2024. PMID: 38983479 Free PMC article.
-
The effects of statins on benign prostatic hyperplasia and the lower urinary tract symptoms: A Meta-analysis.Medicine (Baltimore). 2019 May;98(18):e15502. doi: 10.1097/MD.0000000000015502. Medicine (Baltimore). 2019. PMID: 31045838 Free PMC article.
-
Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.Tzu Chi Med J. 2017 Jan-Mar;29(1):6-11. doi: 10.4103/tcmj.tcmj_3_17. Tzu Chi Med J. 2017. PMID: 28757757 Free PMC article. Review.
-
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol.BMJ Open. 2025 Mar 24;15(3):e094230. doi: 10.1136/bmjopen-2024-094230. BMJ Open. 2025. PMID: 40132822 Free PMC article.
-
International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.Int Urogynecol J. 2013 Feb;24(2):263-7. doi: 10.1007/s00192-012-1818-8. Epub 2012 May 16. Int Urogynecol J. 2013. PMID: 22588143
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical